INARI MEDICAL, INC.

(NARI)
  Report
Delayed Nasdaq  -  04:00 2022-06-29 pm EDT
69.28 USD   -0.12%
06/24BTIG Adjusts Inari Medical's Price Target to $100 from $130, Keeps Buy Rating
MT
06/24INARI MEDICAL, INC.(NASDAQGS : NARI) added to Russell Small Cap Comp Value Index
CI
06/24INARI MEDICAL, INC.(NASDAQGS : NARI) added to Russell 3000E Value Index
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Inari Medical, Inc.(NasdaqGS:NARI) added to S&P 400

05/03/2022 | 12:00am EDT

Inari Medical, Inc.(NasdaqGS:NARI) added to S&P 400


© S&P Capital IQ 2022
All news about INARI MEDICAL, INC.
06/24BTIG Adjusts Inari Medical's Price Target to $100 from $130, Keeps Buy Rating
MT
06/24INARI MEDICAL, INC.(NASDAQGS : NARI) added to Russell Small Cap Comp Value Index
CI
06/24INARI MEDICAL, INC.(NASDAQGS : NARI) added to Russell 3000E Value Index
CI
06/24INARI MEDICAL, INC.(NASDAQGS : NARI) added to Russell 2500 Value Index
CI
06/24INARI MEDICAL, INC.(NASDAQGS : NARI) added to Russell 3000 Value Index
CI
06/24INARI MEDICAL, INC.(NASDAQGS : NARI) added to Russell 2000 Value Index
CI
06/24INARI MEDICAL, INC.(NASDAQGS : NARI) dropped from Russell 2000 Growth-Defensive Index
CI
06/24INARI MEDICAL, INC.(NASDAQGS : NARI) dropped from Russell 2000 Defensive Index
CI
06/21Inari Medical's Shares Rise After Piper Sandler Initiates Coverage
MT
06/21Piper Sandler Starts Inari Medical at Overweight With $100 Price Target
MT
More news
Analyst Recommendations on INARI MEDICAL, INC.
More recommendations
Financials (USD)
Sales 2022 365 M - -
Net income 2022 -38,5 M - -
Net cash 2022 316 M - -
P/E ratio 2022 -93,1x
Yield 2022 -
Capitalization 3 681 M 3 681 M -
EV / Sales 2022 9,22x
EV / Sales 2023 7,71x
Nbr of Employees 800
Free-Float 84,9%
Chart INARI MEDICAL, INC.
Duration : Period :
Inari Medical, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INARI MEDICAL, INC.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 69,28 $
Average target price 105,00 $
Spread / Average Target 51,6%
EPS Revisions
Managers and Directors
William H. Hoffman President, Chief Executive Officer & Director
Mitchell C. Hill Chief Financial Officer
Don B. Milder Chairman
Thomas Tu Chief Medical Officer
Tara Dunn VP-Clinical Affairs & Market Development
Sector and Competitors
1st jan.Capi. (M$)
INARI MEDICAL, INC.-24.09%3 685
MASIMO CORPORATION-53.18%7 608
NOVOCURE LIMITED-4.06%7 533
SHOCKWAVE MEDICAL, INC.8.99%6 999
GETINGE AB-40.22%6 350
IRAY TECHNOLOGY COMPANY LIMITED-8.15%4 986